GRUPO NATURA (NTCO3) Main Indicators
Basic Data - NTCO3
| Company | GRUPO NATURA |
| Corporate Name | NATURA &CO HOLDING S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Gestão de participações societárias em sociedades que desenvolvam suas atividades principais no ramo de beleza. |
| Share | NTCO3 |
| Quote Date | 09/18/2024 |
| Share Type | ON |
| Last Closing | R$ 14.24 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 145.14 M |
| Last Statement | ITR - 06/30/2024 |
| Sector | Consumo não Cíclico |
| Subsector | Produtos de Uso Pessoal e de Limpeza |
| Segment | Produtos de Uso Pessoal |
| Participation Indexes | IBOVESPA, IBRA, IBRX, IBRX50, ICO2, ICON, IGC, IGCT, IGNM, INDX, ISE, ITAG, IVBX, MLCX |
| Updated 09/19/2024 | |
Relative Prices - NTCO3
| Price/Earnings | 7.70 |
| Price/SBV | 0.89 |
| Price/Net Sales | 0.74 |
| Price/CFO | -6.97 |
| Price/FCF | -6.46 |
| Price/Total Assets | 0.48 |
| Price/EBIT | 329.29 |
| Price/Working Capital | 4.43 |
| Price/NCAV | -1.40 |
| EV/EBIT | 398.48 |
| EV/EBITDA | 15.12 |
| EV/Net Sales | 0.89 |
| EV/CFO | -8.43 |
| EV/FCF | -7.82 |
| EV/Total Assets | 0.59 |
| Company Market Cap | R$ 19.75 B |
| Enterprise Value | R$ 23.90 B |
| Current Financial Statement Date | 06/30/2024 |
| Current Share Price | R$ 14.24 |
| Share Price Date | 09/18/2024 |
| Dividend Yield | 5.20% |
| Updated 09/19/2024 | |
Income Statement - NTCO3
| Net Revenue | R$ 26.75 B |
| Gross Result | R$ 17.16 B |
| EBIT | R$ 59.97 M |
| Depreciation and Amortization | - R$ 1.52 B |
| EBITDA | R$ 1.58 B |
| Net Profit | R$ 2.56 B |
| Net Profit/Share | R$ 1.85 |
| Updated 08/12/2024 | |
| Net Revenue | R$ 7.35 B |
| Gross Result | R$ 4.74 B |
| EBIT | R$ 263.83 M |
| Depreciation and Amortization | - R$ 449.75 M |
| EBITDA | R$ 713.58 M |
| Net Profit | - R$ 858.91 M |
| Profit/Share | - R$ 0.62 |
| Updated 08/12/2024 | |
Price and Volume Behavior - NTCO3
| Lowest Price 52 weeks | R$ 11.95 |
| Highest Price 52 weeks | R$ 18.59 |
| Variation 2024 | -11.12% |
| Variation 1 year | -3.99% |
| Variation 2 years(total) | -0.85% |
| Variation 2 years(yearly) | -0.42% |
| Variation 3 years(total) | -68.97% |
| Variation 3 years(yearly) | -32.25% |
| Variation 4 years(total) | -71.32% |
| Variation 4 years(yearly) | -26.81% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 112.01 M |
| Updated 09/19/2024 | |
Returns and Margins - NTCO3
| Return on Initial Tangible Capital | 0.28% |
| Return on Initial Invested Capital | 0.13% |
| Pre-Tax Return on Initial Tangible Capital | 0.42% |
| Pre-Tax Return on Initial Invested Capital | 0.19% |
| Return on Initial Shareholder´s Equity | 12.48% |
| Return on Initial Asset | 5.07% |
| Gross Margin | 64.15% |
| Net Margin | 9.59% |
| EBIT Margin | 0.22% |
| EBITDA Margin | 5.91% |
| Initial Asset Turnover | 0.53 |
| Financial Leverage | 1.83 |
| Liabilities/Net Worth | 0.83 |
| Net Debt/EBITDA | 2.62 |
| Updated 08/12/2024 | |
Balance Sheet - NTCO3
| Cash and Cash Equivalents | R$ 1.60 B |
| Total Assets | R$ 40.76 B |
| Short-Term Debt | R$ 92.04 M |
| Long-Term Debt | R$ 5.65 B |
| Gross Debt | R$ 5.75 B |
| Net Debt | R$ 4.15 B |
| Shareholder´s Equity | R$ 22.24 B |
| Share Book Value | R$ 16.03 |
| Common Shares | 1,386,848,000 |
| Preferred Shares | 0 |
| Total | 1,386,848,000 |
| Common Shares in Treasury | 2,075,000 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 2,075,000 |
| Common Shares (Except Treasury) | 1,384,773,000 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 1,384,773,000 |
| Updated 08/12/2024 | |
Cash Flow - NTCO3
| Operating Cash Flow | - R$ 2.83 B |
| Cash Flow from Investments | R$ 12.00 B |
| Financing Cash Flow | - R$ 9.75 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 678.72 M |
| Updated 08/12/2024 | |
| Operating Cash Flow | - R$ 734.13 M |
| Cash Flow from Investments | - R$ 120.08 M |
| Financing Cash Flow | - R$ 1.83 B |
| Increase (Reduction) in Cash and Equivalents | - R$ 2.59 B |
| Updated 08/12/2024 | |
Experimental - NTCO3
| CAPEX 3 months | - R$ 106.72 M |
| Free Cash Flow 3 months | - R$ 840.85 M |
| CAPEX 12 months | - R$ 222.94 M |
| Free Cash Flow 12 months | - R$ 3.06 B |
| Updated 08/12/2024 | |